OphthalmologyJuly 20200 citations
Systemic β-Blockers Do Not Affect Glaucoma Eye Drop Effectiveness.
Johnson Thomas V, Jampel Henry D
Abstract
No abstract available.
MeSH Terms
Administration, OphthalmicAdrenergic beta-AntagonistsAntihypertensive AgentsCardiovascular DiseasesGlaucoma, Open-AngleHumansIntraocular PressureOphthalmic Solutions
Shields Classification
Related Articles5
Comparative efficacy and safety of preserved versus preservative-free beta-blockers in patients with glaucoma or ocular hypertension: a systematic review.
Systematic ReviewActa Ophthalmol202110 citationsSame chapter
Clinical Dilemma-Topical Prostaglandin Use in Glaucoma During Pregnancy.
Case ReportJAMA Ophthalmol20223 citationsSame chapter
New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost.
ReviewEye (Lond)201968 citationsSame chapter
Long-term betaxolol therapy in glaucoma patients with pulmonary disease.
Clinical TrialAm J Ophthalmol198841 citationsSame chapter
Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma.
Clinical TrialGraefes Arch Clin Exp Ophthalmol199486 citationsSame chapter
Is this article assigned to the wrong chapter(s)? Let us know.